


Healthcare News Roundup: DIagnostics
HSMN NewsFeed - 13 Jul 2018
Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
Kypha Acquires Biosensia - Expands First-in-Class Immune Status Monitoring Platforms
HSMN NewsFeed - 9 Jul 2018
Oculocare's Alleye(R) Receives FDA 510(k) Clearance for Monitoring Eyesight in AMD
Oculocare's Alleye(R) Receives FDA 510(k) Clearance for Monitoring Eyesight in AMD
HSMN NewsFeed - 6 Jul 2018
ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
ITUS Corporation Announces Second Commercial Focus for Cchek(TM) will be Breast Cancer
HSMN NewsFeed - 28 Jun 2018
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
Thermo Fisher Scientific Expands Oncomine Immuno-Oncology Assay Portfolio
HSMN NewsFeed - 27 Jun 2018
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
HSMN NewsFeed - 25 Jun 2018
Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*
Beckman Coulter Files a 510(k) Submission with the FDA for Its Early Sepsis Indicator*
HSMN NewsFeed - 19 Jun 2018
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays
HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
HSMN NewsFeed - 12 Jun 2018
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
HSMN NewsFeed - 31 May 2018
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
